Ischemic Preconditioning, Myocardial
"Ischemic Preconditioning, Myocardial" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Exposure of myocardial tissue to brief, repeated periods of vascular occlusion in order to render the myocardium resistant to the deleterious effects of ISCHEMIA or REPERFUSION. The period of pre-exposure and the number of times the tissue is exposed to ischemia and reperfusion vary, the average being 3 to 5 minutes.
Descriptor ID |
D019157
|
MeSH Number(s) |
E02.592.325 E05.516.325
|
Concept/Terms |
Ischemic Preconditioning, Myocardial- Ischemic Preconditioning, Myocardial
- Myocardial Ischemic Preconditioning
- Preconditioning, Myocardial Ischemic
- Myocardial Preconditioning
- Preconditioning, Myocardial
|
Below are MeSH descriptors whose meaning is more general than "Ischemic Preconditioning, Myocardial".
Below are MeSH descriptors whose meaning is more specific than "Ischemic Preconditioning, Myocardial".
This graph shows the total number of publications written about "Ischemic Preconditioning, Myocardial" by people in this website by year, and whether "Ischemic Preconditioning, Myocardial" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2000 | 1 | 0 | 1 |
2002 | 1 | 3 | 4 |
2003 | 1 | 0 | 1 |
2004 | 1 | 0 | 1 |
2006 | 1 | 0 | 1 |
2011 | 0 | 1 | 1 |
2012 | 0 | 1 | 1 |
2013 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Ischemic Preconditioning, Myocardial" by people in Profiles.
-
Ischemic Preconditioning Confers Epigenetic Repression of Mtor and Induction of Autophagy Through G9a-Dependent H3K9 Dimethylation. J Am Heart Assoc. 2016 12 22; 5(12).
-
The polymorphic and contradictory aspects of intermittent hypoxia. Am J Physiol Lung Cell Mol Physiol. 2014 Jul 15; 307(2):L129-40.
-
Role of uncoupling protein 3 in ischemia-reperfusion injury, arrhythmias, and preconditioning. Am J Physiol Heart Circ Physiol. 2013 May; 304(9):H1192-200.
-
Adaptive and maladaptive cardiorespiratory responses to continuous and intermittent hypoxia mediated by hypoxia-inducible factors 1 and 2. Physiol Rev. 2012 Jul; 92(3):967-1003.
-
Cardiovascular effects of glucagonlike peptide-1 agonists. Am J Cardiol. 2011 Aug 02; 108(3 Suppl):33B-41B.
-
Role of hypoxia-inducible factor in cell survival during myocardial ischemia-reperfusion. Cell Death Differ. 2008 Apr; 15(4):686-90.
-
Opioids and cardioprotection: the impact of morphine and fentanyl on recovery of ventricular function after cardiopulmonary bypass. J Cardiothorac Vasc Anesth. 2006 Aug; 20(4):493-502.
-
Tumor necrosis factor-alpha does not modulate ischemia/reperfusion injury in naïve myocardium but is essential for the development of late preconditioning. J Mol Cell Cardiol. 2004 Jul; 37(1):51-61.
-
Pharmacologic pre-conditioning and controlled reperfusion prevent ischemia-reperfusion injury after 30 minutes of hypoxia/ischemia in porcine hearts. J Heart Lung Transplant. 2003 Nov; 22(11):1234-44.
-
ROS and NO trigger early preconditioning: relationship to mitochondrial KATP channel. Am J Physiol Heart Circ Physiol. 2003 Jan; 284(1):H299-308.